Smurf2 regulates hematopoietic stem cell self-renewal and aging

The age‐dependent decline in the self‐renewal capacity of stem cells plays a critical role in aging, but the precise mechanisms underlying this decline are not well understood. By limiting proliferative capacity, senescence is thought to play an important role in age‐dependent decline of stem cell self‐renewal, although direct evidence supporting this hypothesis is largely lacking. We have previously identified the E3 ubiquitin ligase Smurf2 as a critical regulator of senescence. In this study, we found that mice deficient in Smurf2 had an expanded hematopoietic stem cell (HSC) compartment in bone marrow under normal homeostatic conditions, and this expansion was associated with enhanced proliferation and reduced quiescence of HSCs. Surprisingly, increased cycling and reduced quiescence of HSCs in Smurf2‐deficient mice did not lead to premature exhaustion of stem cells. Instead, HSCs in aged Smurf2‐deficient mice had a significantly better repopulating capacity than aged wild‐type HSCs, suggesting that decline in HSC function with age is Smurf2 dependent. Furthermore, Smurf2‐deficient HSCs exhibited elevated long‐term self‐renewal capacity and diminished exhaustion in serial transplantation. As we found that the expression of Smurf2 was increased with age and in response to regenerative stress during serial transplantation, our findings suggest that Smurf2 plays an important role in regulating HSC self‐renewal and aging.

[1]  D. Ogden,et al.  The fate of serially transplanted bone marrow cell populations from young and old donors. , 1976, Transplantation.

[2]  D. Harrison Competitive repopulation: a new assay for long-term stem cell functional capacity. , 1980, Blood.

[3]  D. Harrison,et al.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure , 1982, The Journal of experimental medicine.

[4]  S. Nishikawa,et al.  In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. , 1992, Blood.

[5]  I. Weissman,et al.  Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  I. Weissman,et al.  The aging of hematopoietic stem cells , 1996, Nature Medicine.

[7]  H. Nakauchi,et al.  In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells. , 1996, Journal of immunology.

[8]  I. Weissman,et al.  In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Scadden,et al.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1. , 2000, Science.

[10]  H. Nakauchi,et al.  Age-Associated Characteristics of Murine Hematopoietic Stem Cells , 2000, The Journal of experimental medicine.

[11]  S. Jacobsen,et al.  Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. , 2001, Immunity.

[12]  T. A. Hewett,et al.  The relative quiescence of hematopoietic stem cells in nonhuman primates. , 2001, Blood.

[13]  Stephen N. Jones,et al.  p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.

[14]  G. van Zant,et al.  The role of stem cells in aging. , 2003, Experimental hematology.

[15]  Jichun Chen,et al.  Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. , 2003, Experimental hematology.

[16]  R. DePinho,et al.  Telomeres, stem cells, senescence, and cancer. , 2004, The Journal of clinical investigation.

[17]  N. Sharpless,et al.  Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.

[18]  K. Mohammad,et al.  Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.

[19]  Stanley N Cohen,et al.  Smurf2 up-regulation activates telomere-dependent senescence. , 2004, Genes & development.

[20]  D. Scadden,et al.  In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C , 2004, Nature Cell Biology.

[21]  G. van Zant,et al.  Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. , 2005, Blood.

[22]  J. Campisi Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[23]  I. Weissman,et al.  Cell intrinsic alterations underlie hematopoietic stem cell aging. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Irving L. Weissman,et al.  Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates , 2005, The Journal of experimental medicine.

[25]  Jiri Bartek,et al.  p16INK4A is a robust in vivo biomarker of cellular aging in human skin , 2006, Aging cell.

[26]  R. DePinho,et al.  Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a , 2006, Nature.

[27]  T. Rando Stem cells, ageing and the quest for immortality , 2006, Nature.

[28]  S. Morrison,et al.  Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing , 2006, Nature.

[29]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[30]  Yan Liu,et al.  The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. , 2006, Cancer cell.

[31]  Namir,et al.  Authors , 1947, Praxis der Kinderpsychologie und Kinderpsychiatrie.

[32]  E. Laurenti,et al.  Dormant and Self‐Renewing Hematopoietic Stem Cells and Their Niches , 2007, Annals of the New York Academy of Sciences.

[33]  L. Donehower,et al.  The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. , 2007, Blood.

[34]  Ronald A. DePinho,et al.  How stem cells age and why this makes us grow old , 2007, Nature Reviews Molecular Cell Biology.

[35]  Chad A Shaw,et al.  Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation , 2007, PLoS biology.

[36]  M. Goodell,et al.  Hematopoietic Stem Cell Aging: Wrinkles In Stem Cell Potential , 2007, Stem Cell Reviews.

[37]  D. Scadden,et al.  Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation , 2008, Nature Reviews Genetics.

[38]  I. Weissman,et al.  Stems Cells and the Pathways to Aging and Cancer , 2008, Cell.

[39]  I. Bernstein,et al.  E47 Controls the Developmental Integrity and Cell Cycle Quiescence of Multipotential Hematopoietic Progenitors1 , 2008, The Journal of Immunology.

[40]  Y. Liu,et al.  p53 regulates hematopoietic stem cell quiescence. , 2009, Cell stem cell.

[41]  I. Weissman,et al.  Evaluation of the Long‐Term Reconstituting Subset of Hematopoietic Stem Cells with CD150 , 2009, Stem cells.

[42]  Yahui Kong,et al.  Smurf2‐mediated ubiquitination and degradation of Id1 regulates p16 expression during senescence , 2011, Aging cell.

[43]  Debashis Sahoo,et al.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age , 2011, Proceedings of the National Academy of Sciences.

[44]  Charusheila Ramkumar,et al.  Smurf2 regulates the senescence response and suppresses tumorigenesis in mice. , 2012, Cancer research.

[45]  Charusheila Ramkumar,et al.  Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1 , 2013, Nature Communications.